KMS Medisurgi Submits Annual Report 2026

KMS Medisurgi Limited has submitted its Annual Report for the Financial Year 2026, as per SEBI regulations. The report includes the Standalone Financial Statements, Directors' Report, and Auditor's Report. Key highlights include the proposed declaration of a final dividend of ₹0.05 per equity share and the re-appointment of Mr. Rohan Devang Kanakia as a Director. The 28th Annual General Meeting is scheduled for September 30, 2026, to adopt the financial statements and approve the dividend.